Pain prediction by serum biomarkers of bone turnover in people with knee osteoarthritis: an observational study of TRAcP5b and cathepsin K in OA

Article English OPEN
Nwosu, Lilian Ngozi ; Allen, Maximillian ; Wyatt, L.A. ; Huebner, J.L. ; Chapman, Victoria ; Walsh, David A. ; Kraus, Virginia (2017)

Objectives: To investigate serum biomarkers, tartrate resistant acid phosphatase 5b (TRAcP5b) and cathepsin K, indicative of osteoclastic bone resorption, and their relationship to pain and pain change in knee osteoarthritis (OA). \ud Methods: Sera and clinical data were collected from 129 people (97 with 3-year follow-up) with knee OA from the Prediction of Osteoarthritis Progression (POP) cohort. Knee OA-related outcomes in POP included: WOMAC pain, NHANES I (pain, aching and stiffness), subchondral sclerosis, and radiographically determined tibiofemoral and patellofemoral OA. Two putative osteoclast biomarkers were measured in sera: TRAcP5b and cathepsin K. Medial tibia plateaux were donated at knee arthroplasty for symptomatic OA (n=84) or from 16 post mortem controls from the Arthritis Research UK (ARUK) Pain Centre joint tissue repository. Osteoclasts were stained for TRAcP within the subchondral bone of the medial tibia plateaux. \ud Results: Serum TRAcP5b activity, but not cathepsin K-immunoreactivity, was associated with density of TRAcP-positive osteoclasts in the subchondral bone of medial tibia plateaux. TRAcP-positive osteoclasts were more abundant in people with symptomatic OA compared to controls. Serum TRAcP5b activity was associated with baseline pain and pain change. \ud Conclusions: Our observations support a role for subchondral osteoclast activity in the generation of OA pain. Serum TRAcP5b might be a clinically relevant biomarker of disease activity in OA.
  • References (30)
    30 references, page 1 of 3

    1. Thomas, E., G. Peat, L. Harris, R. Wilkie, and P.R. Croft, The prevalence of pain and pain interference in a general population of older adults: cross-sectional findings from the North Staffordshire Osteoarthritis Project (NorStOP). Pain 2004; 110(1):361-368.

    2. Creamer, P., Osteoarthritis pain and its treatment. Current Opinion in Rheumatology 2000; 12(5):450-455. T

    3. Felson, D.T., C.E. Chaisson, C.L. Hill, S.M. Totterman, M.E. Gale, K.M. SIkPinner, et al., The association of bone marrow lesions with pain in knee osteoartRhritis. Ann Intern Med 2001; 134(7):541-9. C

    4. Tanamas, S.K., A.E. Wluka, J.-P. Pelletier, J.M. Pelletier, F. ASbram, P.A. Berry, et al., Bone marrow lesions in people with knee osteoarthritis Upredict progression of disease and joint replacement: a longitudinal study. RNheumatology 2010.

    5. Ogino, S., T. Sasho, K. Nakagawa, M. Suzuki, S. AYamaguchi, M. Higashi, et al., Detection of pain-related molecules in the suMbchondral bone of osteoarthritic knees. Clinical Rheumatology 2009; 28(12):1D395-1402.

    6. Salaffi, F., A. Ciapetti, and M. CarEotti, The sources of pain in osteoarthritis: a pathophysiological review. ReuTmatismo 2014; 66(1):57-71.

    7. Strassle, B.W., L. Mark, L. PLeventhal, M.J. Piesla, X. Jian Li, J.D. Kennedy, et al., E Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of C degenerative joint disease. Osteoarthritis and Cartilage 2010; 18(10):1319-1328.

    8. Hunter, D.AJ.,AC.Guermazi, F. Roemer, Y. Zhang, and T. Neogi, Structural correlates of pain in joints with osteoarthritis. Osteoarthritis and Cartilage 2013; 21(9):1170- 1178.

    9. Barr, A.J., T.M. Campbell, D. Hopkinson, S.R. Kingsbury, M.A. Bowes, and P.G. Conaghan, A systematic review of the relationship between subchondral bone ACCEPTED MANUSCRIPT

    Research & Therapy 2015; 17(1):1-36.

  • Similar Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark